Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Mascarenhas, MD
Icahn School of Medicine at Mount Sinai
Study Chair - Ronald Hoffman, MD
Icahn School of Medicine at Mount Sinai
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- Icahn School of Medicine at Mount Sinai
New York, New York, United States
- Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2015
- Primary completion
- 19 Dec 2018
- Completion
- 19 Dec 2018
- Last update posted
- 12 Sept 2019
- Registered enrollment
- 13
- Registry id
- NCT02407080
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.